THEY EITHER NEED TO UPLIST OR MAKE A DEAL. So w

Quote:

---

THEY EITHER NEED TO UPLIST OR MAKE A DEAL.

---

So what do you think would be an appropriate offer that NP and the Board should put up for a vote? Now stop and think about it again. How much is a company worth that has a drug that has shown the best results for m/m in a proper trial. Now add blowing the doors off remdesivir in severe/critical. Now add 60+ potential indications. Now weren't you thinking to low?

Quote:

---

they will have to prove severe beyond a shadow of a doubt p=.0003 at this point.

---

Since remdesivir has no statistical significance for mortality the FDA would be chastised for denying EUA to any drug that does taking the confidence interval into account.